/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of $145.7 billion, Pfizer Inc. (PFE) is a global, research-driven biopharmaceutical company, specializing in the discovery, development, and commercialization of innovative medicines and vaccines across diverse therapeutic areas. With a strong late-stage pipeline and strategic partnerships, Pfizer maintains a robust presence in both established and emerging healthcare markets.
The New York-based company is slated to announce its fiscal Q2 2025 results before the market opens on Tuesday, Aug. 5. Ahead of the event, analysts predict Pfizer to report an adjusted EPS of $0.57, down 5% from $0.60 in the year-ago quarter. However, the company has surpassed Wall Street's bottom-line estimates in the past four quarterly reports. In Q1 2025, PFE exceeded the consensus adjusted EPS estimate by 43.8%.
